Fig. 3From: Patient outcomes of monotherapy with hypofractionated three-dimensional conformal radiation therapy for stage T2 or T3 non-small cell lung cancer: a retrospective studyComparison of local control from radiotherapy with three-dimensional conformal radiation therapy. There was a significant difference between patients who received a dose of <80 Gy and those treated with a dose of ≥80 Gy (P = 0.045)Back to article page